Literature DB >> 30122362

Systems analysis of human vaccine adjuvants.

Ali M Harandi1.   

Abstract

The discovery and wide spread use of vaccines have saved millions of lives in the past few decades. Vaccine adjuvants represent an integral part of the modern vaccines. Despite numerous efforts, however, only a handful of vaccine adjuvants is currently available for human use. A comprehensive understanding of the mechanisms of action of adjuvants is pivotal to harness the potential of existing and new adjuvants in mounting desirable immune responses to counter human pathogens. Decomposing the host response to vaccines and its components at systems level has recently been made possible owing to the recent advancements in Omics technology and cutting edge immunological assays powered by systems biology approaches. This approach has begun to shed light on the molecular signatures of several human vaccines and adjuvants. This review is an attempt to provide an overview of the recent efforts in systems analysis of vaccine adjuvants that are currently in clinic.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adjuvant; Omics; Systems vaccinology; Transcriptomics; Vaccine; Vaccinology

Mesh:

Substances:

Year:  2018        PMID: 30122362     DOI: 10.1016/j.smim.2018.08.001

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  13 in total

1.  Conjugation with 8-arm PEG and CRM197 enhances the immunogenicity of SARS-CoV-2 ORF8 protein.

Authors:  Xiaozhao Tang; Weili Yu; Lijuan Shen; Jinming Qi; Tao Hu
Journal:  Int Immunopharmacol       Date:  2022-06-06       Impact factor: 5.714

2.  Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.

Authors:  Paul-Henri Lambert; Donna M Ambrosino; Svein R Andersen; Ralph S Baric; Steven B Black; Robert T Chen; Cornelia L Dekker; Arnaud M Didierlaurent; Barney S Graham; Samantha D Martin; Deborah C Molrine; Stanley Perlman; Philip A Picard-Fraser; Andrew J Pollard; Chuan Qin; Kanta Subbarao; Jakob P Cramer
Journal:  Vaccine       Date:  2020-05-25       Impact factor: 3.641

Review 3.  Systems vaccinology and big data in the vaccine development chain.

Authors:  René H M Raeven; Elly van Riet; Hugo D Meiring; Bernard Metz; Gideon F A Kersten
Journal:  Immunology       Date:  2018-11-13       Impact factor: 7.397

4.  Caspase-1-Dependent Pyroptosis Mediates Adjuvant Activity of Platycodin D as an Adjuvant for Intramuscular Vaccines.

Authors:  Liyan Zhu; Ziyi Han; Yanfei He; Hongxiang Sun
Journal:  Cells       Date:  2022-01-01       Impact factor: 6.600

Review 5.  Next-Generation Technologies and Systems Biology for the Design of Novel Vaccines Against Apicomplexan Parasites.

Authors:  Mariela Luján Tomazic; Virginia Marugan-Hernandez; Anabel Elisa Rodriguez
Journal:  Front Vet Sci       Date:  2022-01-07

6.  Conserved metabolic enzymes as vaccine antigens for giardiasis.

Authors:  Sozaburo Ihara; Yukiko Miyamoto; Christine H Y Le; Vivien N Tran; Elaine M Hanson; Marvin Fischer; Kurt Hanevik; Lars Eckmann
Journal:  PLoS Negl Trop Dis       Date:  2022-04-25

Review 7.  Current Challenges in Vaccinology.

Authors:  Richard B Kennedy; Inna G Ovsyannikova; Peter Palese; Gregory A Poland
Journal:  Front Immunol       Date:  2020-06-25       Impact factor: 7.561

Review 8.  Recent advances in influenza vaccines.

Authors:  Graham Pawelec; Janet McElhaney
Journal:  F1000Res       Date:  2020-04-28

Review 9.  Toward precision adjuvants: optimizing science and safety.

Authors:  Etsuro Nanishi; David J Dowling; Ofer Levy
Journal:  Curr Opin Pediatr       Date:  2020-02       Impact factor: 2.856

10.  Immune-Enhancing Activity of Aqueous Extracts from Artemisia rupestris L. via MAPK and NF-kB Pathways of TLR4/TLR2 Downstream in Dendritic Cells.

Authors:  Yu Yang; DanYang Wang; QuanXiao Li; Jiang He; Bin Wang; Jinyao Li; Ailian Zhang
Journal:  Vaccines (Basel)       Date:  2020-09-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.